Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Carpediem(TM) Post Market Surveillance Study

NCT04608149 is registered in ClinicalTrials.gov with Mozarc Medical US LLC as lead sponsor.

NCT NCT04608149
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04608149 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Carpediem(TM) Post Market Surveillance Study
Lead sponsor
Mozarc Medical US LLC
Phase
Observational
Overall status
Completed
Start date
January 20, 2021
Completion date
April 30, 2026
Enrollment
36 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

acute kidney injury, fluid overload